AGP Executive Report
Last update: 4 hours agoRegulatory Watch: India’s CDSCO has approved QDENGA, Takeda’s dengue vaccine, for ages 4–60—an important step as dengue cases and deaths remain high. Policy & Access: Wisconsin begins implementing a law extending postpartum Medicaid coverage from 60 days to a year, aiming to reduce gaps in care and prevent avoidable deaths. Clinical Breakthrough: A Michigan Medicine-led trial found a daily heart-failure polypill improved cardiac function and cut hospital/ER visits by 60%, published in Nature Medicine. Public Health & Outbreak Response: WHO is enrolling its first treatment trial for the Bundibugyo Ebola strain in Congo, testing MBP-134 and remdesivir. Healthcare Systems & Safety: South Dakota’s rural EMS funding fight escalates as Rapid City’s fire department warns it may stop covering rural areas after 2026 without new funding. Pharma & Industry: Samsung Biologics announced a CHF 1.46B acquisition of PolyPeptide to scale peptide manufacturing, targeting growing demand tied to obesity and diabetes therapies. Medical Ethics & Courts: India’s Delhi High Court orders Safdarjung Hospital to file Sonam Wangchuk’s medical reports and will decide Tuesday on a request to move him to a private facility.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
